Search details
1.
Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin.
Pharmaceuticals (Basel)
; 15(1)2021 Dec 24.
Article
in English
| MEDLINE | ID: mdl-35056076
2.
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
J Immunother Cancer
; 9(3)2021 03.
Article
in English
| MEDLINE | ID: mdl-33753569
Results
1 -
2
de 2
1
Next >
>>